Lv4
570 积分 2022-12-21 加入
Advances in PSMA-targeted therapy for prostate cancer
23小时前
待确认
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
2个月前
已完结
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
2个月前
已完结
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
2个月前
已完结
Multiple myeloma
3个月前
已完结
Multiple myeloma
3个月前
已完结
Tazemetostat and doxorubicin in patient-derived preclinical models of epithelioid sarcoma (ES)
3个月前
已完结
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
3个月前
已完结
Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration
3个月前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer
皖公网安备34019202002308
